Geprägs, Alina
Bürgin, David
Fegert, Jörg M.
Brähler, Elmar
Clemens, Vera
Funding for this research was provided by:
Universität Ulm
Article History
Received: 13 September 2022
Accepted: 1 February 2023
First Online: 20 February 2023
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Medical Department of the University of Leipzig (Protocol Number: 298/21‐ek; Date of Approval: 12.7.2021). All participants provide informed consent.
: Not applicable.
: AG, DB, EB and VC declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. JMF has received research funding from EU, BMG, BMBF, BMFSFJ, DFG, G-BA Innovation Fund, State Ministries of Baden-Württemberg and Saarland, Landesstiftung Baden-Württemberg, Porticus Stiftung, Evangelische Landeskirche Baden-Württemberg, travel grants, speakers' fees, event and training sponsorship from APK, Adenauer and Ebert Foundations, Deutschlandfunk, DFG, DJI, DKSB, Infectopharm, med update, UNICEF, professional associations, universities and federal and state ministries. JMF is consultant for APK, federal and state ministries. JMF has no industry-sponsored lecture series, no shareholdings, no participation in pharmaceutical companies.